Application of Circulating Exosomes in Early Diagnosis and Prognosis Evaluation After Intracerebral Hemorrhage

Tang-Du Hospital1 site in 1 country300 target enrollmentSeptember 12, 2021

ConditionsIntracerebral Hemorrhage；Circulating Exosomes

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Intracerebral Hemorrhage；Circulating Exosomes
Sponsor: Tang-Du Hospital
Enrollment: 300
Locations: 1
Primary Endpoint: The type and content of circulating exosomes
Last Updated: 4 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to observe the relationship between the changes of circulating exosomes and the development and outcome of the disease in patients with intracerebral hemorrhage, and to search for early serum markers and potential intervention targets for disease monitoring in patients with intracerebral hemorrhage

Registry

clinicaltrials.gov

Start Date

September 12, 2021

End Date

July 31, 2022

Last Updated

4 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Tang-Du Hospital

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•No systematic treatment was given before admission;
•The patients were diagnosed with cerebral hemorrhage, and had imaging evidence;
•The age was more than 18 years old;
•The patient or family member agrees to sign the informed consent.

Exclusion Criteria

•Hematoma is caused by secondary factors (intracranial tumor, arteriovenous malformation or aneurysm);
•Bleeding into the ventricle;
•Multiple cerebral hemorrhage;
•The patient did not receive treatment in our hospital;
•Severe disability, dementia, or organ dysfunction before onset
•Coagulopathy or long-term use of anticoagulants
•Hematoma affects brain stem
•Subjects refused to participate